Proteomics-based identification of secreted protein dihydrodiol dehydrogenase 2 as a potential biomarker for predicting cisplatin efficacy in advanced NSCLC patients-Reference-Cited by-同舟云学术

Proteomics-based identification of secreted protein dihydrodiol dehydrogenase 2 as a potential biomarker for predicting cisplatin efficacy in advanced NSCLC patients

Published:2012-08 Issue:2 Volume:77 Page:427-432
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Kuang Peng,Zhou Caicun,Li Xuefei,Ren Shengxiang,Li Bing,Wang Yongsheng,Li Jiayu,Tang Liang,Zhang Jie,Zhao Yinmin

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference38 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Chemotherapy hemoresistance and the changing treatment landscape for NSCLC;Chang;Lung Cancer,2011

3. Non-small-cell lung cancer;Goldstraw;Lancet,2011

4. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N Engl J Med,2002

5. Cisplatin: a review of toxicities and therapeutic applications;Barabas;Vet Comp Oncol,2008

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomes Derived from Irradiated-Prostate Cancer Cells Promote Cancer Progression;Journal of Medical and Biological Engineering;2024-08

2. Function, drug resistance and prognostic effect of AKR1C2 in human cancer;Neoplasma;2023

3. Proteomics reveals a therapeutic vulnerability via the combined blockade of APE1 and autophagy in lung cancer A549 cells;BMC Cancer;2020-07-08

4. Diagnostic value of serum dihydrodiol dehydrogenase 2 levels in patients with non-small-cell lung cancer;The International Journal of Biological Markers;2018-06-06

5. Identification of Novel Protein Expression Changes Following Cisplatin Treatment and Application to Combination Therapy;Journal of Proteome Research;2017-09-29